Department of Hepatobiliary Surgery, The Third Affiliated Hospital of Sun Yat-Sen University, 510630, Guangzhou, People's Republic of China.
Dig Dis Sci. 2010 Sep;55(9):2664-9. doi: 10.1007/s10620-009-1053-4. Epub 2009 Dec 1.
Curative percutaneous microwave coagulation therapy is difficult or contraindicated in patients with tumors adjacent to the gallbladder because of the associated risk of injury. To date, no clinical data have been published regarding the effects and safety of percutaneous microwave coagulation therapy on tumors that are adjacent to the gallbladder.
We investigated the efficacy and safety of a combined treatment involving laparoscopic cholecystectomy and subsequent percutaneous microwave coagulation therapy in patients with hepatocellular carcinoma adjacent to the gallbladder.
Twenty-three patients with hepatocellular carcinoma nodules (of less than 5 cm diameter) and adjacent to the gallbladder were treated by percutaneous microwave coagulation therapy with a "cooled-tip needle" after laparoscopic cholecystectomy. The therapeutic efficacy was evaluated with enhanced helical computed tomography and sonography, and the rates of complete necrosis as well as postoperative complications were also analyzed.
All of the patients exhibited complete necrosis of their tumor lesions after treatment with percutaneous microwave coagulation therapy. During the follow-up period (which lasted more than 21 months), 22 of 23 patients were alive. Recurrent nodules appeared in other subsegments, but not at the original site treated with percutaneous microwave coagulation therapy. Of note, no fatal complications were observed in any of the patients treated with percutaneous microwave coagulation therapy.
Our results suggest that combined treatment comprising both laparoscopic cholecystectomy and subsequent percutaneous microwave coagulation therapy is an effective and safe approach for patients with small (<5 cm) hepatocellular carcinomas that are adjacent to the gallbladder.
由于存在胆囊损伤的风险,对于毗邻胆囊的肿瘤,根治性经皮微波凝固治疗较为困难或禁忌。目前,尚未有关于毗邻胆囊的肿瘤行经皮微波凝固治疗的效果和安全性的临床数据。
我们旨在探讨联合应用腹腔镜胆囊切除术和随后的经皮微波凝固治疗对毗邻胆囊的肝细胞癌的疗效和安全性。
对 23 例直径小于 5 cm 的毗邻胆囊的肝细胞癌结节患者,在腹腔镜胆囊切除术后采用“冷循环针”进行经皮微波凝固治疗。采用增强螺旋 CT 和超声检查评估疗效,并分析完全坏死率和术后并发症发生率。
所有患者经经皮微波凝固治疗后肿瘤病灶均完全坏死。在随访期(超过 21 个月)内,23 例患者中 22 例存活。在其他亚段出现复发性结节,但在经皮微波凝固治疗的原部位未出现。值得注意的是,在接受经皮微波凝固治疗的患者中未观察到致命性并发症。
对于毗邻胆囊的小肝癌(<5 cm),联合应用腹腔镜胆囊切除术和随后的经皮微波凝固治疗是一种有效且安全的方法。